Login to My NLA Account

Member Publications

This page was last updated: Aug 24, 2018

Regional Activities and Events

$

This page was last updated: Aug 24, 2018

Last Updated: Tuesday, 17-Jul-2018 18:15:00 EDT

JACKSONVILLE, Fla. — Due to high demand, the rooming block at the Loews Vanderbilt Hotel in Nashville is sold out for the 2018 Fall Clinical Lipid Update.

Those planning to attend the Fall CLU are encouraged to explore other area hotels.

For additional information, visit lipid.org/fallclu.

Last Updated: Friday, 06-Jul-2018 13:00:00 EDT

 

JACKSONVILLE, Fla. — The National Lipid Association announced on Friday the recipients of its 2018-19 Junior Faculty Research Awards for Clinical Science and Basic Science.

Last Updated: Monday, 02-Jul-2018 16:30:00 EDT

Last Updated: Monday, 11-Jun-2018 01:15:00 EDT

Last Updated: Thursday, 10-May-2018 21:15:00 EDT


SILVER SPRING, Md. – National Lipid Association Board Member Lori Alexander, MSHS, RD, CCRC, CLS, FNLA testified on Thursday, May 10 in front of the Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee on behalf of familial chylomicronemia patients. The committee held a hearing regarding the safety and efficacy of a new treatment for FCS, volanesorsen.

 

Article By:

0
No votes yet

DS: Thank you for joining me today Fran. First, I would like to introduce myself and then you to the LipidSpin readers. I am Dan Soffer, a full-time internist, clinical lipidologist and educator at the University of Pennsylvania. I am also President-Elect of the Northeast Lipid Association (NELA) and co-editor of LipidSpin.

Article By:

FRAN BURKE MS, RD

University of Pennsylvania Health System
Preventive Cardiology Radnor and Perelman Center for Advanced Medicine
Philadelphia, PA

Moderator: DANIEL SOFFER, MD, FACP, FNLA

Internal Medicine/Clinical Lipidology
University of Pennsylvania Health System
Philadelphia, PA
Diplomate, American Board of Clinical Lipidology

0
No votes yet

After an article by Drs. Peter H. Jones and James M. McKenney in LipidSpin one year ago1 that reported on emerging therapeutics in clinical lipidology, it is still a very exciting time for the development of novel treatments for dyslipidemic patients.

Article By:

MARINA CUCHEL, MD, PhD

Research Associate Professor of Medicine
Division of Translational Medicine and Human Genetics
University of Pennsylvania
Philadelphia, PA

ARCHNA BAJAJ, MD, MSCE

Post-doctoral Fellow
Division of Translational Medicine and Human Genetics
University of Pennsylvania
Philadelphia, PA

0
No votes yet